Disparities: Study Finds Risk in Off-... - New York Times

PsychCentral.comDisparities: Study Finds Risk in Off-Label PrescribingNew York TimesAnd one in three doctors who used lorazepam (often marketed as Ativan) to treat chronic anxiety thought it had been approved for this use; in fact, ...Off-label use of drugs: How much does your doctor know?MinnPost.comall 13 news articles »